CellaVision AB (publ) (OTCMKTS:CLVSF) Trading Up 1.8% – Here’s What Happened

Shares of CellaVision AB (publ) (OTCMKTS:CLVSF) rose 1.8% during trading on Thursday . The stock traded as high as $17.30 and last traded at $17.30. Approximately 400 shares were traded during mid-day trading, an increase of 60% from the average daily volume of 250 shares. The stock had previously closed at $17.00.

CellaVision AB (publ) Price Performance

The business has a 50-day moving average of $16.89 and a 200 day moving average of $18.38.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.